Refractory, metastatic hormone-refractory Prostate cancer
Also known as: Hormone-refractory prostate cancer metastatic / Metastatic Hormone Refractory Prostate Cancer / Metastasis from hormone-refractory prostate cancer (disorder) / Castration-resistant prostate cancer / Hormone-refractory prostate cancer / Hormone refractory prostate cancer (disorder)
Drug | Drug Name | Drug Description |
---|---|---|
DB01248 | Docetaxel | A taxoid antineoplastic agent used in the treatment of various cancers, such as locally advanced or metastatic breast cancer, metastatic prostate cancer, gastric adenocarcinoma, and head and neck cancer. |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB05812 | Abiraterone | 1 | Active Not Recruiting | 1 |
DB08875 | Cabozantinib | 1 | Active Not Recruiting | 1 |
DB09035 | Nivolumab | 1 | Active Not Recruiting | 1 |
DB00635 | Prednisone | 1 | Active Not Recruiting | 1 |
DB01248 | Docetaxel | 2 | Completed | 1 |
DB03010 | Patupilone | 2 | Completed | 1 |
DB00635 | Prednisone | 2 | Completed | 1 |